We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Unveiling Medical Properties (MPW) Q4 Outlook: Wall Street Estimates for Key Metrics
Read MoreHide Full Article
Wall Street analysts forecast that Medical Properties (MPW - Free Report) will report quarterly earnings of $0.16 per share in its upcoming release, pointing to a year-over-year decline of 55.6%. It is anticipated that revenues will amount to $220.77 million, exhibiting an increase of 280.4% compared to the year-ago quarter.
The current level reflects a downward revision of 5.5% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
Given this perspective, it's time to examine the average forecasts of specific Medical Properties metrics that are routinely monitored and predicted by Wall Street analysts.
Analysts' assessment points toward 'Revenues- Rent billed' reaching $159.60 million. The estimate indicates a change of +103.5% from the prior-year quarter.
Analysts forecast 'Revenues- Income from financing leases' to reach $9.80 million. The estimate indicates a year-over-year change of -49.5%.
It is projected by analysts that the 'Real estate depreciation and amortization' will reach $159.39 million. Compared to the present estimate, the company reported $77.30 million in the same quarter last year.
Shares of Medical Properties have experienced a change of +3.8% in the past month compared to the -0.5% move of the Zacks S&P 500 composite. With a Zacks Rank #4 (Sell), MPW is expected to underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Unveiling Medical Properties (MPW) Q4 Outlook: Wall Street Estimates for Key Metrics
Wall Street analysts forecast that Medical Properties (MPW - Free Report) will report quarterly earnings of $0.16 per share in its upcoming release, pointing to a year-over-year decline of 55.6%. It is anticipated that revenues will amount to $220.77 million, exhibiting an increase of 280.4% compared to the year-ago quarter.
The current level reflects a downward revision of 5.5% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
Given this perspective, it's time to examine the average forecasts of specific Medical Properties metrics that are routinely monitored and predicted by Wall Street analysts.
Analysts' assessment points toward 'Revenues- Rent billed' reaching $159.60 million. The estimate indicates a change of +103.5% from the prior-year quarter.
Analysts forecast 'Revenues- Income from financing leases' to reach $9.80 million. The estimate indicates a year-over-year change of -49.5%.
It is projected by analysts that the 'Real estate depreciation and amortization' will reach $159.39 million. Compared to the present estimate, the company reported $77.30 million in the same quarter last year.
View all Key Company Metrics for Medical Properties here>>>
Shares of Medical Properties have experienced a change of +3.8% in the past month compared to the -0.5% move of the Zacks S&P 500 composite. With a Zacks Rank #4 (Sell), MPW is expected to underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>